Cite
HARVARD Citation
Farren, M. et al. (2015). Selinexor, a selective inhibitor of nuclear export (SINE), shows enhanced activity in combination with PD-1/PD-L1 blockade in syngeneic murine models of colon cancer and melanoma. Journal for immunotherapy of cancer. 3 (2), pp. 1-2. [Online].